10/11/2024 - Here is a new SELL breakout chosen mechanically:10/11/2024 - Here is a new SELL breakout chosen mechanically:
Stop @ $21.31
Entry SELL @ $19.78 or less
Target @ $17.24
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.83 EUR
537.91 M EUR
19.34 B EUR
209.63 M
About FRESEN.MED.CARE KGAA O.N.
Sector
Industry
CEO
Helen Giza
Website
Headquarters
Bad Homburg
Founded
2006
ISIN
DE0005785802
FIGI
BBG000DHXTF1
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.
FME • Fresenius Medical Care • LONG#FME • Fresenius Medical Care • XETRA LONG TF H4
TP = 45.35 , SL = 39.59
The trend continues, the nearest support level according to my calculations TP 45.35
ABC/DTarget is D.
Possible stop under C.
I own this and it is a slow but a steady mover.
I scooped this up very close to the bottom and have not been disappointed.
Not yet anyway LOL.
The market has a way of biting me when I least expect it but I plan to hang.
No recommendation.
ATH 57.94
EARNINGS 8-2/
Cup and HandleResistance overhead from a prior gap down. OVERBOUGHT using standard RSI set at 70.
Cup low is 12.79.
Earnings 5-9-23.
This company is in Germany and provides dialysis to kidney failure patients. There are clinics al over the US owned by this company providing a service that kidney failure pati
Bottom FishingAscending Triangle.
ATL is 3.35.
3 year low is 12.79 which was made recently.
ATH 57.94.
Another dialysis company that is not based in the USA, so as a rule there would be no dividend.
Dialysis is not going away unfortunately and these dialysis sessions 3 times a week will always be covered as far
$FMS with a Bearish outlook following its earnings #Stocks The PEAD projected a Bearish outlook for $FMS after a Negative Under reaction following its earnings release placing the stock in drift D with an expected accuracy of 33.33%.
$FMS with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $FMS after a Positive over reaction following its earnings release placing the stock in drift B with an expected accuracy of 71.43%.
Long FME After Earnings ReportHi Traders!
𝗧𝗵𝗲 𝗶𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗮𝗻𝗮𝗹𝘆𝘀𝗶𝘀 𝘀𝗵𝗮𝗿𝗲𝗱 𝗶𝗻 𝘁𝗵𝗶𝘀 video 𝗶𝘀 𝗻𝗼𝘁 𝗳𝗶𝗻𝗮𝗻𝗰𝗶𝗮𝗹 𝗮𝗱𝘃𝗶𝗰𝗲.
𝗔𝗹𝘄𝗮𝘆𝘀 𝗰𝗼𝗻𝗱𝘂𝗰𝘁 𝘆𝗼𝘂𝗿 𝗼𝘄𝗻 𝗮𝗻𝗮𝗹𝘆𝘀𝗶𝘀 𝗮𝗻𝗱 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵.
Happy trading!
FMC Trade with MOUNT Germany 30 Quant SystemTrading is Waiting - Quants have a lot of time and wait until they the setup fits their requirements.
Traderama uses quant based "buy the valley" strategies for equity trading. This is an example, that the best returns will be achieved if you find the bottom and trade the bounce.
This trade example
FMS Technical Analysis 🧙Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients in roughly 4,000 clinics across the globe as of December 2019. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and conc
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
F
FMS5184425
Fresenius Medical Care US Finance III, Inc. 3.0% 01-DEC-2031Yield to maturity
5.90%
Maturity date
Dec 1, 2031
F
US35805BAA61
FreMedCarUSFin3 3,75% 15/06/2029 Rule 144AYield to maturity
5.65%
Maturity date
Jun 15, 2029
F
FMS5184423
Fresenius Medical Care US Finance III, Inc. 1.875% 01-DEC-2026Yield to maturity
4.98%
Maturity date
Dec 1, 2026
See all FME bonds
Related stocks
Frequently Asked Questions
The current price of FME is 44.61 EUR — it has increased by 4.84% in the past 24 hours. Watch FRESEN.MED.CARE KGAA O.N. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on XETR exchange FRESEN.MED.CARE KGAA O.N. stocks are traded under the ticker FME.
FME stock has risen by 4.89% compared to the previous week, the month change is a 1.68% rise, over the last year FRESEN.MED.CARE KGAA O.N. has showed a 26.66% increase.
We've gathered analysts' opinions on FRESEN.MED.CARE KGAA O.N. future price: according to them, FME price has a max estimate of 57.50 EUR and a min estimate of 37.00 EUR. Watch FME chart and read a more detailed FRESEN.MED.CARE KGAA O.N. stock forecast: see what analysts think of FRESEN.MED.CARE KGAA O.N. and suggest that you do with its stocks.
FME stock is 2.75% volatile and has beta coefficient of 0.63. Track FRESEN.MED.CARE KGAA O.N. stock price on the chart and check out the list of the most volatile stocks — is FRESEN.MED.CARE KGAA O.N. there?
Today FRESEN.MED.CARE KGAA O.N. has the market capitalization of 12.78 B, it has decreased by −8.06% over the last week.
Yes, you can track FRESEN.MED.CARE KGAA O.N. financials in yearly and quarterly reports right on TradingView.
FRESEN.MED.CARE KGAA O.N. is going to release the next earnings report on May 6, 2025. Keep track of upcoming events with our Earnings Calendar.
FME earnings for the last quarter are 0.91 EUR per share, whereas the estimation was 0.80 EUR resulting in a 13.94% surprise. The estimated earnings for the next quarter are 0.81 EUR per share. See more details about FRESEN.MED.CARE KGAA O.N. earnings.
FRESEN.MED.CARE KGAA O.N. revenue for the last quarter amounts to 5.07 B EUR, despite the estimated figure of 4.75 B EUR. In the next quarter, revenue is expected to reach 4.71 B EUR.
FME net income for the last quarter is 67.00 M EUR, while the quarter before that showed 213.03 M EUR of net income which accounts for −68.55% change. Track more FRESEN.MED.CARE KGAA O.N. financial stats to get the full picture.
Yes, FME dividends are paid annually. The last dividend per share was 1.19 EUR. As of today, Dividend Yield (TTM)% is 2.73%. Tracking FRESEN.MED.CARE KGAA O.N. dividends might help you take more informed decisions.
FRESEN.MED.CARE KGAA O.N. dividend yield was 3.26% in 2024, and payout ratio reached 78.55%. The year before the numbers were 3.13% and 69.97% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 15, 2025, the company has 113.84 K employees. See our rating of the largest employees — is FRESEN.MED.CARE KGAA O.N. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. FRESEN.MED.CARE KGAA O.N. EBITDA is 3.26 B EUR, and current EBITDA margin is 16.44%. See more stats in FRESEN.MED.CARE KGAA O.N. financial statements.
Like other stocks, FME shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FRESEN.MED.CARE KGAA O.N. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So FRESEN.MED.CARE KGAA O.N. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating FRESEN.MED.CARE KGAA O.N. stock shows the neutral signal. See more of FRESEN.MED.CARE KGAA O.N. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.